GAL3ST2 and neoplasm: No significant differences in the scoring were detected for CHST1 and Gal3ST4, whereas Gal3ST2 displayed a significant decrease (p < 0.0001) in expression comparing benign and borderline tissue with malignant tumor tissue (Fig. 8B).